These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 15452855

  • 1. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M.
    J Comp Neurol; 2004 Nov 08; 479(2):198-215. PubMed ID: 15452855
    [Abstract] [Full Text] [Related]

  • 2. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC.
    J Comp Neurol; 2004 May 17; 473(1):97-106. PubMed ID: 15067721
    [Abstract] [Full Text] [Related]

  • 3. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D, Cruz-Muros I, Alvarez de la Rosa D, Abreu P, Giráldez T, Castro-Hernández J, Salas-Hernández J, Lanciego JL, Rodríguez M, González-Hernández T.
    Neurobiol Dis; 2009 Dec 17; 36(3):494-508. PubMed ID: 19766189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Exp Neurol; 2004 Jul 17; 188(1):65-73. PubMed ID: 15191803
    [Abstract] [Full Text] [Related]

  • 9. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration.
    Lu W, Wolf ME.
    Brain Res Mol Brain Res; 1997 Oct 03; 49(1-2):137-48. PubMed ID: 9387873
    [Abstract] [Full Text] [Related]

  • 10. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
    Szot P, White SS, Veith RC, Rasmussen DD.
    Alcohol Clin Exp Res; 1999 Oct 03; 23(10):1643-9. PubMed ID: 10549997
    [Abstract] [Full Text] [Related]

  • 11. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 12. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
    Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ.
    Ann Neurol; 1996 Sep 24; 40(3):428-39. PubMed ID: 8797532
    [Abstract] [Full Text] [Related]

  • 13. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ.
    Mov Disord; 1997 Nov 24; 12(6):885-97. PubMed ID: 9399211
    [Abstract] [Full Text] [Related]

  • 14. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 15. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI.
    J Comp Neurol; 1997 Nov 17; 388(2):211-27. PubMed ID: 9368838
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May 17; 293(2):329-35. PubMed ID: 10772999
    [Abstract] [Full Text] [Related]

  • 17. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN, Ryoo H, Cox C, Lu W.
    J Comp Neurol; 1995 Nov 20; 362(3):400-10. PubMed ID: 8576447
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal.
    Duchemin AM, Zhang H, Neff NH, Hadjiconstantinou M.
    Neurosci Lett; 2009 Dec 25; 467(2):182-6. PubMed ID: 19835933
    [Abstract] [Full Text] [Related]

  • 19. Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection.
    Pan T, Xie W, Jankovic J, Le W.
    Neurosci Lett; 2005 Mar 29; 377(2):106-9. PubMed ID: 15740846
    [Abstract] [Full Text] [Related]

  • 20. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 29; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.